Companies Cryptocurrencies
Lumos Pharma Inc
Lumos Pharma Inc
Exchange: NasdaqGM
IPO Date: 11/11/2011
CEO: Mr. Richard J. Hawkins
Biotechnology Healthcare 🔗
  • LUMO
  • 8.31
  • 69548304
    market cap
  • 0.21000004
If you bought

shares of Lumos Pharma Inc (LUMO) on
You would have made
Old Price $12 Current Price $12

Lumos Pharma, Inc., formerly NewLink Genetics Corporation, is a clinical stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for rare diseases. Its lead product candidate is LUM-201, an oral growth hormone stimulating therapeutic, is in late stage clinical development for the treatment of Pediatric Growth Hormone Deficiency (PGHD). LUM-201 is an orally administered small molecule that promotes the secretion (secretagogue) of Growth Hormone (GH) from the pituitary gland. LUM-201 acts as an agonist of the GH Secretagogue Receptor to stimulate GH release. The Company’s pipeline features development programs in rare diseases associated with growth hormone deficiencies.

Address: 4200 MARATHON BLVD. SUITE 200 Austin TEXAS 78756

Stay updated.